News
11h
MedPage Today on MSNFirst-Line Immunotherapy Combo Boosts Survival in Unresectable Liver CancerFirst-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...
Research from The University of Western Australia has advanced the development of cancer treatments that enable immune cells ...
2hon MSN
CAR-T cell therapy, a revolutionary cancer treatment, is now under scrutiny due to potential cognitive complications like ...
3d
Verywell Health on MSNImmunotherapy Helps Some Cancer Patients Avoid Surgery, Study FindsA study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...
Merck’s Phase III KEYNOTE-B96 trial shows significant overall and progression-free survival gains with Keytruda plus ...
A promising new study is changing the way doctors think about treating certain cancers. The research focuses on immunotherapy ...
Teddi Mellencamp is giving a glimpse into her cancer recovery journey.
Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...
2don MSN
Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy ...
Teddi Mellencamp gave an update on her health, including her tumors and her body's response to immunotherapy, during the ...
The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...
An immuno-based treatment targeting cancer cells with mismatch repair-deficiency could help those with the disease treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results